AEY

Fuck off scam

EBS

Emergent BioSolutions' NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
Emergent has officially shipped its over the counter, original prescription strength NARCAN® Naloxone HCl Nasal Spray 4 mg to leading mass, drug/pharmacy and grocery stores, as well as online retailers

NARCAN® Nasal Spray will be the first, life-saving emergency medicine for opioid overdose available on shelves beginning this September with a Manufacturer's Suggested Retail Price of $44.99
Emergent remains committed to ensuring broad access, awareness and strong supply for essential public interest groups leading naloxone distribution efforts across the country

GAITHERSBURG, Md., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE:EBS) announced NARCAN® Naloxone HCl Nasal Spray 4 mg will be available on shelves nationwide and online beginning in September. Over-the-counter (OTC) access to NARCAN® Nasal Spray offers more people the ability to respond in an opioid emergency, helping to save lives and keep loved ones and communities safe. Expanding access and awareness is critical given the staggering toll of the epidemic mainly driven by synthetic opioids, like fentanyl.1 Last year, approximately every seven minutes one life was lost due to an opioid overdose, and today it is the leading cause of accidental death in the U.S.2,3 The average response time for emergency services to arrive is approximately 10 minutes.4 Having NARCAN® Nasal Spray in a first-aid kit, or carrying it on the go in case of an opioid emergency, can make a difference and help reverse the effects of opioids while waiting for emergency personnel to arrive.

"As a medical professional and mom who experienced the unthinkable and lost both of her sons to accidental overdose, I know you can't put a price on peace of mind and there is no act too great to protect family," said Dr. Bonnie Milas, Penn Medicine physician and professor of Clinical Anesthesiology and Critical Care. "Picking up NARCAN® Nasal Spray at the store is not a sign that your family has "a problem," in fact it shows you are prepared just in case. It's like buying a fire extinguisher to have at home – having the power to save a life of someone you love, someone you know, or someone that may need another chance."

With the same safe and effective 4 mg formulation, device design and original prescription strength, NARCAN® Nasal Spray can reverse the effects of opioids, including fentanyl. Consumers can expect the life-saving treatment to be widely available at leading mass, drug, grocery and online retailers beginning in September. The Manufacturer's Suggested Retail Price of NARCAN® Nasal Spray is $44.99 per carton, which is equivalent to roughly $22.50 per dose. While Emergent works with partners to help maintain access and affordability, the price of the product is set by individual retailers.

"A steadfast commitment to expanding access to naloxone has always been at the forefront of our work to help save lives and we're proud to bring NARCAN® Nasal Spray to many, many more places," said Paul Williams, senior vice president, products business. "Expanding availability to online and in-store shelves, increasing awareness and education to reduce stigma, and calling on the public to be prepared, is additive to the current work Emergent does every single day to stem the tide of this public health threat. On the eve of International Overdose Awareness Day, we stand by our ongoing efforts with advocates, patients, customers and policy stakeholders to implement efforts that enhance naloxone distribution to all those in need."

As a leader in the fight against the opioid crisis, Emergent has not raised the price of the product since its launch in 2016, and the company is focused on broadening distribution and maintaining affordability. To that end, Emergent has lowered its public interest price for NARCAN® Nasal Spray to $41.00 per two-dose carton, effective August 31, 2023, building on its long-standing efforts with public interest partners to ensure naloxone is readily available to at-risk communities. Through federal grants and state and local government programs, many community organizations, first responders, and harm reduction groups can purchase NARCAN® Nasal Spray and distribute it at no cost to them. These programs help ensure life-saving products are available in communities across the country, particularly those that may be unable to reach life-saving medical care quickly in emergencies. While the public interest distribution channels are vast, many qualified groups can continue to use Emergent's online portal, NARCANDirect™, as one pathway to purchase and ship bulk quantities of NARCAN® Nasal Spray to anywhere in the country.

According to a March 2023 report by the Reagan-Udall Foundation, almost 17 million doses of naloxone were distributed in the U.S. in 2021. More than 84 percent of those doses were distributed through channels such as local health departments, harm reduction organizations, first responders, schools, and other community organizations.5 Emergent recognizes the importance of these channels for naloxone access and will continue to support ongoing distribution to high-risk and underserved communities in need.

With the prescription approval of NARCAN® Nasal Spray in 2015, Emergent has more than seven years of real-world safety data, and continues to evaluate trends across society, new opioid threats and is committed to doing its part in fighting the opioid epidemic.

For more information, visit NARCAN.com.

About NARCAN® Nasal Spray

Yo, everyone here and on all boards. I’m buying 10k shares starting now. I’m going to buy in 100 share increments looking to counter the shorts. Let’s all do our part. This stock is so undervalued. See for yourself

This isn’t one of those pumps. Bid at the Ask confidently on this one.

Is there any hope to take action to 2.34 again (AEY)

plz download Amazing Real time stock screener app With free news ? : Android: https://dwz1.cc/zkNVfOg
iOS: https://dwz1.cc/uJQCj9R
The Best Stock Screener App Review So Far：
https://dwz1.cc/CjfRfWk

This is from the CEO in the earnings PR on 5/14/19:

"The telecommunications segment reported sales of $8.7 million, which is an increase of 24% as compared to second quarter of 2018 and 27% compared to the first quarter of 2019. This was driven by strong sales momentum at both Nave Communications and Triton Datacom. Most notably, Nave increased revenue by 39% as compared to the first quarter of 2019. A milestone was reached in the telecommunications segment this quarter by reporting positive EBITDA of $0.3 million, a vast improvement over previous quarters, which further solidifies our growth strategy and demonstrates the success of the operational improvements in the telecommunications segment," Mr. Hart continued.

The drag last quarter was the new Fulton acquisition with a $1.1M operating loss. But they were upbeat on the last conference call about Fulton. The PR last week confirmed that optimism, saying Fulton already turned profitable in April. That's why the stock jumped last Thursday. Just a small preview of what's to come here. From the PR on 5/30/19:

Joe Hart, President and CEO of the Company, stated, "The sale of the Cable TV segment is a milestone for ADDvantage, which will allow us to focus our capital and resources on our expansion strategy in the Wireless Infrastructure Services and Telco segments. The transaction also provides us with an infusion of cash to allow us to capitalize on the major growth opportunities in the industry, as wireless and fiber networks continue to expand. We believe that the recent positive results of our Telco segment, led by Nave Communications, demonstrate the success of the Company's new strategy shift. Triton Datacom is nearing the completion of its new facility in Pembroke Park, FL, which will provide additional space for expansion and process improvements. We are also excited about the revenue and profitability growth at Fulton Technologies, which has now moved beyond its integration period and is on track to contribute positive results in our fiscal third quarter, as evidenced by its profitable April results. ADDvantage Technologies is now entering a new chapter, and we are delighted that 76% of our shareholders participated in this shareholder vote with 99% of those voting in favor of the proposed sale of the Cable TV segment."

Unlike in recent years, this new management team is executing beautifully so far. AEY going to post big revenue increases for the next several quarters, and start posting positive earnings vs. year ago losses. Plus we now have a 5G kicker with Fulton. Few people know about the turnaround underway here. This low floater has limited downside considering they just sold their Cable biz for $10.3M...ALONG with multi-bagger upside potential as the remaining Telco & Wireless Infrastructure segments continue their rapid growth. A very favorable risk/reward situation imo.